‘All the data we have right now suggests alcohol causes more harm than cannabis. That’s the hypothesis.’
Tag Archives: Multiple Sclerosis
A conflicted clinical trial finds treatment for MS is “safe” but “largely ineffective”
A long-awaited study into Paolo Zamboni’s treatment yields disappointment for most sufferers—yet hope of relief for a few
An MS trial reported ‘definitive’ results before it was done. Why?
Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions
A new ‘cure’ for MS? Not so fast.
The stem cell treatment for MS greeted as a “cure” is a breakthrough for five per cent of people with MS. What about the other 95 per cent?
Why MS scientists are taking aim at Canada’s new science minister
Anne Kingston on how the criticism levelled at Kirsty Duncan over a controversial MS treatment is surprisingly unscientific
Are we on the cusp of a revolution in how we understand the brain?
Two new studies suggest a potential game-changer in how scientists understand of the brain, which could advance research on MS and Alzheimer’s
Could Canada cause multiple sclerosis?
The cheeky rebranding of multiple sclerosis in Canada raises the fair question: why are rates so high here?
CCSVI 2013: ‘debunking,’ spin, and legal drama
Anne Kingston on the MS research that captured headlines in 2013
Shorter CCSVI explainer: Time to liberate liberation treatment
Last week’s shut-down of the Albany, NY clinical trial investigating CCSVI treatment due to lack of patient enrollment is a big set-back on a number of fronts. It’s bad news for the Saskatchewan government, which allocated $2.2 million and recruited patients to travel to the U.S.—and a blow for those who’d taken part in the trial or were lined up to go. But, like all failures, it’s instructive.
Time to liberate ‘liberation’ therapy from MS
Anne Kingston explains why we’ve reached the WTF moment in CCSVI research